$90,000 of LEGEND BIOTECH CORPORATION lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Advance Legend Biotech's interests with respect to educating member of Congress on the importance of the role of biotechnology in healthcare"
You can find more data on corporate lobbying on Quiver Quantitative.
LEGN Insider Trading Activity
LEGN insiders have traded $LEGN stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $LEGN stock by insiders over the last 6 months:
- YING HUANG (Chief Executive Officer) has made 0 purchases and 2 sales selling 15,502 shares for an estimated $169,404.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
LEGN Hedge Fund Activity
We have seen 107 institutional investors add shares of LEGN stock to their portfolio, and 82 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FIRST BEIJING INVESTMENT LTD added 2,296,335 shares (+inf%) to their portfolio in Q1 2026, for an estimated $41,540,700
- ASSENAGON ASSET MANAGEMENT S.A. added 1,915,056 shares (+inf%) to their portfolio in Q2 2026, for an estimated $55,306,817
- KYNAM CAPITAL MANAGEMENT, LP added 1,576,295 shares (+inf%) to their portfolio in Q1 2026, for an estimated $28,515,176
- ALLIANCEBERNSTEIN L.P. removed 1,517,067 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $27,443,742
- FMR LLC added 1,428,517 shares (+5.9%) to their portfolio in Q1 2026, for an estimated $25,841,872
- TWO SIGMA INVESTMENTS, LP added 1,364,326 shares (+259.3%) to their portfolio in Q1 2026, for an estimated $24,680,657
- POINT72 ASSET MANAGEMENT, L.P. added 1,101,211 shares (+39.5%) to their portfolio in Q1 2026, for an estimated $19,920,906
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
LEGN Analyst Ratings
Wall Street analysts have issued reports on $LEGN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 01/20/2026
To track analyst ratings and price targets for LEGN, check out Quiver Quantitative's $LEGN forecast page.
LEGN Price Targets
Multiple analysts have issued price targets for $LEGN recently. We have seen 6 analysts offer price targets for $LEGN in the last 6 months, with a median target of $56.0.
Here are some recent targets:
- Leonid Timashev from RBC Capital set a target price of $63.0 on 07/07/2026
- Mitchell S. Kapoor from HC Wainwright & Co. set a target price of $65.0 on 06/03/2026
- Ashwani Verma from UBS set a target price of $49.0 on 06/03/2026
- Yaron Werber from TD Cowen set a target price of $29.0 on 05/13/2026
- Matthew Harrison from Morgan Stanley set a target price of $48.0 on 05/13/2026
- Gena Wang from Barclays set a target price of $80.0 on 02/04/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
